Vasopharm's Series D Round

Vasopharm raised a round of funding on May 04, 2009.

Vasopharm develops therapeutics for acute inflammatory central nervous system conditions by targeting nitric oxide signaling pathways. The company focuses on drug development in central nervous system…

Articles about Vasopharm's Series D Round: